Posted by Michael Wonder on 04 Jul 2022
DoH publishes revised agenda for next week's PBAC meeting
4 July 2022 - Apparently the webpage was last updated on 29 July 2022.
Version 2 of the agenda for the July 2022 PBAC meeting is now available.
- Tezepelumab (Tezspire) – To be considered at a future PBAC meeting
- Cytosine arabinoside with daunorubicin (nanoparticle, liposomal) (Vyxeos) - Withdrawn
